Backed by select partnerships with Phase I Specialty Units and a tenured team, CRC consistently reaches milestones under tight clinical timelines in early phase studies. Learn how our strategic approach and robust collaboration led to dosing the last subject two weeks ahead of schedule while maintaining data quality in the case study below.
Need Support
200 Central Ave, Ste. 1200
St. Petersburg, Florida 33701
Stay Connected with CRC
Join our newsletter to stay connected with the world of CRC. From case studies and scientific papers to networking opportunities.